Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
FDA approves Rozlytrek for cancers with certain gene mutations
Yung S. Lie, PhD, is the president and CEO of the Damon Runyon Cancer Research Foundation.
Lynparza maintenance therapy after chemotherapy nearly doubled progression-free survival.
The Affordable Care Act erases racial disparities in care for advanced cancers.
First KRAS targeted therapy shows promise for lung and colon cancer
What to give—or add to your wish
At her lowest ebb, breast cancer survivor Amanda Enayati, our cover subject, discovered serenity.
The cancer is particularly difficult to treat with traditional therapies.
Exposure to natural light or bright light therapy can lead to well-needed rest among people with cancer.
The drug, a PARP inhibitor, blocks proteins that help repair damaged DNA, and so can cause tumor cells that carry a BRCA mutation to die.
I often think of how I was a shadow of myself on chemotherapy this time last year, and how much stronger I am now in comparison.
In non-small cell lung cancer, new drugs like brigatinib and crizotinib can dramatically shrink tumors with an ALK alteration.
I have felt beyond safe, loved for and cared about at Sloan — every visit, every procedure, every follow-up.
Today, 16 states require insurance plans to cover fertility preservation care when treatment like chemotherapy risks infertility.
Mutation revelation is a boon in an era of targeted therapies, say oncologists at UCSF, Children’s National Health System.
Today, instead of volunteering at my kids’ school for Halloween, I am at Sloan for my pre-op testing and meeting with the surgeon.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.